{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:10:22Z","timestamp":1778721022965,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.thromres.2026.109689","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:59:00Z","timestamp":1776668340000},"page":"109689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bridging laboratory assays, genetics, and clinical phenotypes in antithrombin deficiency: Rethinking the diagnostic paradigm"],"prefix":"10.1016","volume":"261","author":[{"given":"Tamara","family":"Rojnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"\u0160ket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Slapnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bla\u017e","family":"Vrhov\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alenka","family":"Mavri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maru\u0161a","family":"Debeljak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojca","family":"Bo\u017ei\u010d Mijovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.thromres.2026.109689_bb0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1055\/s-0044-1786807","article-title":"Thrombophilia screening: not so straightforward","volume":"50","author":"Moore","year":"2024","journal-title":"Semin. Thromb. Hemost."},{"issue":"10","key":"10.1016\/j.thromres.2026.109689_bb0010","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1007\/s00277-024-05926-2","article-title":"Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis","volume":"103","author":"Alnor","year":"2024","journal-title":"Ann. Hematol."},{"issue":"10","key":"10.1016\/j.thromres.2026.109689_bb0015","first-page":"868","article-title":"Antithrombin deficiency as a still underdiagnosed thrombophilia: a primer for internists","volume":"130","author":"Bravo-Perez","year":"2020","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2026.109689_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/mas.21929","article-title":"Antithrombin: deficiency, diversity, and the future of diagnostics","author":"Kruijt","year":"2025","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.thromres.2026.109689_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2018.07.008","article-title":"The genetics of antithrombin","volume":"169","author":"Corral","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109689_bb0030","author":"The Human Gene Mutation Database (HGMD)"},{"issue":"1","key":"10.1016\/j.thromres.2026.109689_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.14648","article-title":"Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH","volume":"18","author":"Van Cott","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109689_bb0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jth.13252","article-title":"Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort","volume":"14","author":"Gindele","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2026.109689_bb0045","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1182\/blood-2006-08-040774","article-title":"Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis","volume":"109","author":"Corral","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2026.109689_bb0050","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/jth.12364","article-title":"Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture","volume":"11","author":"Puurunen","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109689_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0040-1716531","article-title":"Antithrombin p.Thr147Ala: the first founder mutation in people of African origin responsible for inherited Antithrombin deficiency","volume":"121","author":"Orlando","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2026.109689_bb0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1751-553X.2011.01307.x","article-title":"The phenotypic and genetic assessment of antithrombin deficiency","volume":"33","author":"Cooper","year":"2011","journal-title":"Int. J. Lab. Hematol."},{"issue":"6","key":"10.1016\/j.thromres.2026.109689_bb0065","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2001-11-0047","article-title":"Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?","volume":"99","author":"Ungerstedt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109689_bb0070","article-title":"Diagnostic performance of commercial antithrombin activity assays: do we get what we expect?","author":"Orlando","year":"2025","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2026.109689_bb0075","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1309\/AJCPVY4Z9XZMFOTH","article-title":"The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency","volume":"140","author":"Kovacs","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.thromres.2026.109689_bb0080","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.thromres.2015.03.013","article-title":"Antithrombin heparin binding site deficiency: a challenging diagnosis of a not so benign thrombophilia","volume":"135","author":"Orlando","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109689_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2017.10.023","article-title":"Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center","volume":"160","author":"Gindele","year":"2017","journal-title":"Thromb. Res."},{"issue":"13\u201314","key":"10.1016\/j.thromres.2026.109689_bb0090","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.clinbiochem.2014.06.013","article-title":"Discordant diagnoses obtained by different approaches in antithrombin mutation analysis","volume":"47","author":"Feddersen","year":"2014","journal-title":"Clin. Biochem."},{"issue":"8","key":"10.1016\/j.thromres.2026.109689_bb0095","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jtha.2025.05.021","article-title":"Hidden antithrombin defects: time to change and improve our thrombophilia diagnostic approach","volume":"23","author":"Corral","year":"2025","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109689_bb0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1160\/TH14-05-0446","article-title":"Genetic analysis should be included in clinical practice when screening for antithrombin deficiency","volume":"113","author":"Zeng","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109689_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.thromres.2026.109689_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.thromres.2026.109689_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100142","article-title":"Hemostatic defects in congenital disorders of glycosylation","volume":"7","author":"Pascreau","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109689_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.thromres.2020.02.025","article-title":"Seventeen novel SERPINC1 variants causing hereditary antithrombin deficiency in a Czech population","volume":"189","author":"Provaznikova","year":"2020","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2026.109689_bb0130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1160\/TH16-08-0635","article-title":"GFHT study group on genetic thrombophilia, thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency","volume":"117","author":"Alhenc-Gelas","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"7\u20138","key":"10.1016\/j.thromres.2026.109689_bb0135","first-page":"512","article-title":"Genetic characterization of antithrombin, protein C, and protein S deficiencies in polish patients","volume":"127","author":"Wypasek","year":"2017","journal-title":"Pol. Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2026.109689_bb0140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1160\/TH10-08-0538","article-title":"Molecular basis of antithrombin deficiency","volume":"105","author":"Luxembourg","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109689_bb0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2019.01.022","article-title":"SERPINC1 variants causing hereditary antithrombin deficiency in a Danish population","volume":"175","author":"Kjaergaard","year":"2019","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2026.109689_bb0150","first-page":"249","article-title":"Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency","volume":"111","author":"Luxembourg","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109689_bb0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajh.26413","article-title":"Molecular and clinical characterization of transient antithrombin deficiency: a new concept in congenital thrombophilia","volume":"97","author":"Bravo-Perez","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109689_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MBC.0000000000000816","article-title":"A series of 10 polish patients with thromboembolic events and antithrombin deficiency: two new c.1154-1 G>C and c.1219-534 a>G SERPINC1 gene splicing mutations","volume":"30","author":"Wojcik","year":"2019","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.thromres.2026.109689_bb0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1160\/TH11-12-0875","article-title":"Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort","volume":"108","author":"Caspers","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2026.109689_bb0170","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/jth.13372","article-title":"Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect","volume":"14","author":"de la Morena-Barrio","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109689_bb0175","author":"The Genome Aggregation Database (gnomAD)"},{"issue":"4","key":"10.1016\/j.thromres.2026.109689_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1160\/TH11-09-0671","article-title":"Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from southern Italy","volume":"107","author":"Castaldo","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2026.109689_bb0185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jmoldx.2022.01.009","article-title":"Molecular dissection of structural variations involved in Antithrombin deficiency","volume":"24","author":"de la Morena-Barrio","year":"2022","journal-title":"J. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.thromres.2026.109689_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24055023","article-title":"Usefulness and limitations of multiple ligation-dependent probe amplification in Antithrombin deficiency","volume":"24","author":"Cifuentes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2026.109689_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-0040-1718400","article-title":"The role of epigenetics in the regulation of hemostatic balance","volume":"47","author":"Danese","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.thromres.2026.109689_bb0200","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/s-0040-1720980","article-title":"Comparison of DNA methylation profiles of hemostatic genes between liver tissue and peripheral blood within individuals","volume":"121","author":"Olsson Lindvall","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109689_bb0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2013.05.012","article-title":"Great discrepancy in antithrombin activity measured using five commercially available functional assays","volume":"132","author":"Javela","year":"2013","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2026.109689_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040544","article-title":"Investigation of the differences in Antithrombin to heparin binding among Antithrombin Budapest 3, Basel, and Padua mutations by biochemical and in silico methods","volume":"11","author":"Gindele","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.thromres.2026.109689_bb0215","doi-asserted-by":"crossref","first-page":"16734","DOI":"10.1038\/s41598-023-43941-x","article-title":"Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis","volume":"13","author":"Rojnik","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2026.109689_bb0220","first-page":"146","article-title":"Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency","volume":"116","author":"Navarro-Fernandez","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2026.109689_bb0225","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1160\/TH08-09-0583","article-title":"Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis","volume":"101","author":"Roldan","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"19","key":"10.1016\/j.thromres.2026.109689_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012877","article-title":"Inherited thrombophilia and the risk of arterial ischemic stroke: a systematic review and Meta-analysis","volume":"8","author":"Chiasakul","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"16","key":"10.1016\/j.thromres.2026.109689_bb0235","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.109.913673","article-title":"Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies","volume":"121","author":"Kenet","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.thromres.2026.109689_bb0240","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCULATIONAHA.113.003756","article-title":"Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study","volume":"129","author":"Di Minno","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.thromres.2026.109689_bb0245","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jth.13960","article-title":"Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study","volume":"16","author":"Sokol","year":"2018","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:22:43Z","timestamp":1778718163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"alternative-id":["S0049384826001088"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109689","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging laboratory assays, genetics, and clinical phenotypes in antithrombin deficiency: Rethinking the diagnostic paradigm","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109689"}}